BRTX huge volume and some movementCurrently @ 1.45 with some massive volume coming in. Grabbed some shares for a possible target just under 2.00
Next report date
Report period
Q1 2024
EPS estimate
−0.51USD
Revenue estimate
30.00 KUSD
−3.54USD
−14.42 MUSD
145.80 KUSD
4.90 M
About BioRestorative Therapies, Inc.
Sector
Industry
CEO
Lance Alstodt
Website
Headquarters
Melville
Employees (FY)
11
Founded
1997
FIGI
BBG000BNB165
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
We've lost the number of times we shorted BRTX.Goals 3.89, 3.36. Invalidation at 5.46.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere
BRTX Price TargetOn 12/1/2021 E. Piros from Roth Capital brokerage Initiated Coverage on BRTX with a Buy rating and a price target of $37.00.
The price is now 4.57usd.
2 Week Range 4.36 - 132! yes, 132usd!
We can expect a big pump after this all time low!
BioRestorative Therapies Announced few days ago the Fili
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BRTX is 1.23 USD — it has decreased by 3.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioRestorative Therapies, Inc. stocks are traded under the ticker BRTX.
BioRestorative Therapies, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
BRTX stock is 5.79% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is BioRestorative Therapies, Inc. there?
BRTX earnings for the last quarter are −0.64 USD per share, whereas the estimation was −0.68 USD resulting in a 5.88% surprise. The estimated earnings for the next quarter are −0.69 USD per share. See more details about BioRestorative Therapies, Inc. earnings.
BioRestorative Therapies, Inc. revenue for the last quarter amounts to 31.00 K USD despite the estimated figure of 30.00 K USD. In the next quarter revenue is expected to reach 30.00 K USD.
Yes, you can track BioRestorative Therapies, Inc. financials in yearly and quarterly reports right on TradingView.
BRTX stock has fallen by 5.38% compared to the previous week, the month change is a 12.14% fall, over the last year BioRestorative Therapies, Inc. has showed a 68.94% decrease.
BRTX net income for the last quarter is −2.83 M USD, while the quarter before that showed −2.93 M USD of net income which accounts for 3.43% change. Track more BioRestorative Therapies, Inc. financial stats to get the full picture.
Today BioRestorative Therapies, Inc. has the market capitalization of 8.60 M, it has increased by 5.34% over the last week.
No, BRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioRestorative Therapies, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 11.00 employees. See our rating of the largest employees — is BioRestorative Therapies, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioRestorative Therapies, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioRestorative Therapies, Inc. stock shows the sell signal. See more of BioRestorative Therapies, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BioRestorative Therapies, Inc. future price: according to them, BRTX price has a max estimate of 15.00 USD and a min estimate of 6.00 USD. Read a more detailed BioRestorative Therapies, Inc. forecast: see what analysts think of BioRestorative Therapies, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioRestorative Therapies, Inc. EBITDA is −15.00 M USD, and current EBITDA margin is −10.33 K%. See more stats in BioRestorative Therapies, Inc. financial statements.